Neurology - Research & Surgery

Neurology - Research & Surgery

Open Access
ISSN: 2641-4333
Review Article

Opioid-Free Anesthesia Plus Postoperative Management Focused on Anti- Hyperalgesia Approach in Patients with Joint Hypermobility Syndrome Undergoing Occipital-Cervical Fixation: A Narrative Review and Authors' Perspective

Authors: Ramírez-Paesano Carlos R, Juanola Galceran Albert, Gilete García Vicenc, Oliver Abadal Bartolomé, Rodiera Clarens Claudia, Rodiera Olivé Josep, Santaliestra Fierro Jesús, Mora Granizo Francisco.

DOI: 10.33425/2641-4333.1030


Abstract

 Cranio-cervical instability has been well identified in diseases with connective tissue like Ehlers-Danlos Syndrome- Hypermobility Type/Joint Hypermobility Syndrome. It is frequently associated with functional gastrointestinal disturbances, mast cell activation syndrome, and autonomic symptoms as postural orthostatic tachycardia syndrome. These patients suffer from chronic fatigue, and severe widespread pain of exceedingly difficult management and poor control with opioids. Chronic neuroinflammation, opioid-induced hyperalgesia, and Central Sensitization phenomena may explain this complex and painful condition.

The aim of this narrative review is to present updated information on the peri-operative considerations of patients with Ehlers-Danlos Syndrome-Hypermobility Type/Joint Hypermobility Syndrome and cranio-cervical instability who are undergoing Occipital-Cervical Fixation/Fusion. Our protocol of opioid-free total intravenous anesthesia will also be described. Acute post-operative pain management includes the use of a combination of anti-hyperalgesic coadjuvants (lidocaine, ketamine and dexmedetomidine) with an opioid-sparing effect.

View / Download PDF
Citation: Ramírez-Paesano Carlos R, Juanola Galceran Albert, Gilete García Vicenc, et al. Opioid-Free Anesthesia Plus Postoperative Management Focused on Anti- Hyperalgesia Approach in Patients with Joint Hypermobility Syndrome Undergoing Occipital-Cervical Fixation: A Narrative Review and Authors' Perspective. 2020; 3(2). DOI: 10.33425/2641-4333.1030
Editor-in-Chief
Inaki Arrotegui
Inaki Arrotegui
Department of Neurosurgery | Zaragoza University

View full editorial board →
Journal Metrics
Impact Factor 1.2*
Acceptance Rate 80%
Time to first decision 6-10 Days
Submission to acceptance 12-15 Days